XML 64 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2015
Fair Value of Financial Instruments  
Schedule of fair value of the financial assets and liabilities

 

In accordance with the fair value hierarchy described above, the following tables show the fair value of the Company’s financial assets and liabilities that are required to be measured at fair value, in thousands:

 

 

 

Fair Value Measurements at

 

 

 

March 31, 2015

 

 

 

(unaudited)

 

 

 

 

 

 

 

Significant

 

 

 

 

 

Total Carrying

 

Quoted Prices

 

Other

 

Significant

 

 

 

Value at

 

in Active

 

Observable

 

Unobservable

 

 

 

March 31,

 

Markets

 

Inputs

 

Inputs

 

 

 

2015

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

25,810 

 

$

25,810 

 

$

 

$

 

Marketable securities

 

39,026 

 

 

39,026 

 

 

Long term marketable securities

 

27,315 

 

 

27,315 

 

 

Marketable securities - restricted (SERP)

 

267 

 

 

267 

 

 

Total assets at fair value

 

$

92,418 

 

$

25,810 

 

$

66,608 

 

$

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

$

2,691 

 

$

 

$

 

$

2,691 

 

 

 

 

Fair Value Measurements at

 

 

 

December 31, 2014

 

 

 

 

 

 

 

Significant

 

 

 

 

 

Total Carrying

 

Quoted Prices

 

Other

 

Significant

 

 

 

Value at

 

in Active

 

Observable

 

Unobservable

 

 

 

December 31,

 

Markets

 

Inputs

 

Inputs

 

 

 

2014

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

Assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

36,396 

 

$

36,396 

 

$

 

$

 

Marketable securities

 

37,940 

 

 

37,940 

 

 

Long term marketable securities

 

19,816 

 

 

19,816 

 

 

Marketable securities - restricted (SERP)

 

305 

 

 

305 

 

 

Total assets at fair value

 

$

94,457 

 

$

36,396 

 

$

58,061 

 

$

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Derivative liabilities

 

$

6,564 

 

$

 

$

 

$

6,564 

 

 

Schedule of Level 3 liabilities included in Non-current Liabilities on the Balance Sheet

The following table presents information about the Company’s Level 3 liabilities as of December 31, 2014 and March 31, 2015 that are included in the Non-Current Liabilities section of the Consolidated Balance Sheets, in thousands:

 

 

 

Three Months ended

 

 

 

March 31,

 

 

 

2015

 

 

 

(unaudited)

 

 

 

 

 

Balance at December 31, 2014

 

$

6,564

 

 

 

 

 

Changes in fair value of derivative liabilities included in earnings

 

49

 

Reduction due to conversion of debt to equity

 

(3,922

)

 

 

 

 

Balance at March 31, 2015

 

$

2,691

 

 

Schedule of unrestricted marketable securities

 

Unrestricted marketable securities held by the Company were as follows, in thousands:

 

At March 31, 2015 (unaudited):

 

Available for Sale

 

Amortized
Cost

 

Gross
Unrealized
Gains

 

Gross
Unrealized
Losses

 

Fair Value

 

Corporate debt securities

 

$

66,406

 

$

15

 

$

(80

)

$

66,341

 

 

At December 31, 2014:

 

Available for Sale

 

Amortized
Cost

 

Gross
Unrealized
Gains

 

Gross
Unrealized
Losses

 

Fair Value

 

Corporate debt securities

 

$

57,910

 

$

4

 

$

(158

)

$

57,756

 

 

Schedule of contractual maturities of the unrestricted available for sale marketable securities held

 

The contractual maturities of the unrestricted available for sale marketable securities held by the Company were as follows, in thousands:

 

 

 

March 31,

 

 

 

2015

 

 

 

(unaudited)

 

Less Than 1 Year

 

$

39,026 

 

1-5 years

 

27,315 

 

Greater Than 5 Years

 

 

Total

 

$

66,341 

 

 

Interest make-whole liability  
Fair value of financial instruments  
Schedule of assumptions used to calculate fair value of liabilities

 

Volatility

 

45%

 

Stock Price as of March 31, 2015

 

$12.09 per share

 

Credit Spread

 

1388 bps

 

Term

 

2.1 years

 

Dividend Yield

 

0.0%

 

 

Warrant to purchase common stock  
Fair value of financial instruments  
Schedule of assumptions used to calculate fair value of liabilities

 

Exercise Price

 

$4.00 - $5.00 per share

Volatility

 

65%

Stock Price as of March 31, 2015

 

$12.09 per share

Term

 

5.8 - 6.8 years

Dividend Yield

 

0.0%

Risk-Free Rate

 

1.5% -1.7%